Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Masimo’s noninvasive patient monitoring technologies are widely adopted globally. Their SET® pulse oximetry has been validated in over a hundred independent studies to outperform conventional pulse oximeters—especially under challenging conditions like motion or low perfusion—and has contributed to improved clinical outcomes such as reduced retinopathy of prematurity and better detection of critical congenital heart disease. The company’s platforms are used on more than two hundred million patients annually worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Masimo.